
Multinational biopharmaceutical company.
Senior Associate, Content Production–Label Updates
福利厚生
•健康保険
•401k
•ストックオプション
•フレックスタイム
•Learning Budget
必須スキル
Regulatory Compliance
Content Management
Project Coordination
Documentation
Career Category
Marketing
Job Description
Our Global Content Production group’s mission is to empower Amgen brands with a centralized, technology-driven Content Production capability.
About the role:
The Sr. Associate, Content Production – Label Updates is responsible for coordinating and managing activities related to Label Update development (LUD) across Amgen brands and devices. This role ensures timely communication, alignment, and execution of content and artwork changes impacted by FDA label updates. The incumbent will collaborate closely with Regulatory, Content Production, Marketing, and Labelling teams to ensure all promotional and labelling materials are accurate and compliant with the latest regulatory guidance.
This is central to shaping our digital content strategy, enhancing operational efficiency, and delivering seamless, scalable, and compliant content experiences on scale.
Key Responsibilities:Artwork & Content Management
Oversee artwork and content updates for IFUs and Promotional Content Labelling (PCL), ensuring regulatory accuracy, design integrity, and timely execution. Partner with internal design and production teams to maintain compliance and quality standards.
Regulatory Alignment & Label Governance
Lead coordination across Brand Sponsors, MAC, Regulatory, Brand Label coordinators and communicate the impact of label updates (LUDs) on promotional materials, labelling, and. Ensure visibility into FDA timing, brand implications, and readiness plans for Content Production.
Information Stewardship & Communication
Drive consistent information flow on label updates across internal teams, external partners, and vendors, delivering daily insights and weekly summaries to all stakeholders. Maintain rigorous documentation and version control to ensure traceability, transparency, and alignment across internal and external collaborators.
Operational Excellence & Continuous Improvement
Anticipate cross-functional needs, streamline label update workflows, and champion process enhancements that improve efficiency, communication, and regulatory readiness across global and regional teams.
Qualifications & Skills:Basic Qualifications:
- Bachelor’s degree and 4+ years of relevant experience in labelling, regulatory affairs, content production, or pharmaceutical marketing operations.
Preferred Qualifications:
- Proven Experience in Regulated Pharmaceutical or Biotechnology Environments.
- Applies deep understanding of compliance-driven operations and documentation standards to ensure quality and audit readiness.
- Comprehensive Knowledge of FDA Labeling Regulations and Promotional Review Processes.
- Demonstrates fluency in regulatory expectations governing labeling accuracy, claims substantiation, and promotional content review.
- Exceptional Organizational Skills and Meticulous Attention to Detail.
- Manages complex deliverables and competing priorities with precision, ensuring accuracy and consistency across all outputs.
- Effective Communication and Cross-Functional Collaboration.
- Engages seamlessly with regulatory, medical, legal, and marketing partners to drive alignment and operational efficiency.
- Advanced Proficiency in Document and Artwork Management Systems.
- Utilizes platforms such as Veeva Vault, Promo Mats, or equivalent systems to maintain version control, ensure compliance, and streamline review workflows.
Competencies
- Regulatory and Compliance Acumen
- Demonstrates deep understanding of regulatory frameworks and ensures alignment with global standards and governance requirements.
- Stakeholder Engagement and Cross-Functional Collaboration
- Builds strong partnerships across internal teams, external partners, and vendors to drive alignment and shared accountability.
- Strategic and Clear Communication
- Delivers information with precision, transparency, and consistency to enable informed decision-making at all levels.
- Process Optimization and Workflow Excellence
- Designs, implements, and refines efficient systems that enhance quality, speed, and compliance throughout operational processes.
- Ownership and Execution Accountability
- Follows through commitments with integrity, driving outcomes and maintaining accountability for results.
.
閲覧数
0
応募クリック
0
Mock Apply
0
スクラップ
0
類似の求人

EPC / Construction Project Controls Internship (m/f/d) - Gigafactory Berlin-Brandenburg
Tesla · Grünheide (mark), Brandenburg

Vehicle Service Technician, Parramatta
Tesla · Parramatta, New South Wales

Delivery Advisor
Tesla · Alcobendas, Md

Purchasing Lead, Cell Project Engineering
Tesla · Austin, Texas

Service Technician
Tesla · Gainesville, Florida
Amgenについて

Amgen
PublicA biotechnology company that develops and manufactures human therapeutics for various illnesses and diseases.
10,001+
従業員数
Thousand Oaks
本社所在地
$138B
企業価値
レビュー
24件のレビュー
3.6
24件のレビュー
ワークライフバランス
3.2
報酬
3.5
企業文化
3.1
キャリア
2.8
経営陣
3.4
65%
知人への推奨率
良い点
Excellent benefits and health benefits
Good pay and compensation
Supportive management and leadership
改善点
Limited career growth and promotion opportunities
Work-life balance challenges and long hours
Bureaucratic processes
給与レンジ
1,002件のデータ
Junior/L3
L2
L6
Mid/L4
Senior/L5
Director
L3
L4
L5
Junior/L3 · Associate Fuel Operations
2件のレポート
$99,200
年収総額
基本給
$80,652
ストック
-
ボーナス
-
$99,200
$99,200
面接レビュー
レビュー5件
難易度
3.0
/ 5
期間
14-28週間
内定率
40%
体験
ポジティブ 20%
普通 80%
ネガティブ 0%
面接プロセス
1
Application Review
2
Recruiter Screen
3
Hiring Manager Interview
4
Technical/Case Interview
5
Final Round/Panel Interview
6
Offer
よくある質問
Technical Knowledge
Behavioral/STAR
Past Experience
Case Study
Culture Fit
最新情報
FDA turns up heat on Amgen, proposing to rescind approval of Tavneos
HN
·
1w ago
·
1
·
1
Amgen posts Q1 results April 30; anyone can hear the webcast live - Stock Titan
Stock Titan
News
·
1w ago
AMGEN ANNOUNCES WEBCAST OF 2026 FIRST QUARTER FINANCIAL RESULTS - Yahoo Finance
Yahoo Finance
News
·
1w ago
Amgen’s Chief Technology Officer Dr David Reese to retire - European Pharmaceutical Review
European Pharmaceutical Review
News
·
1w ago